Cosmos Health Inc.(COSM)— Stock Profile, AI Score & Financials

Consumer Staples · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Cosmos Health Inc. (COSM) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores COSM at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,616 of 2,962 stocks — the bottom half of the AI-ranked universe. COSM scores in the top quartile across revenue growth (77.0). Areas of concern include earnings quality (4.5) and balance sheet strength (5.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 29.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cosmos Health Inc. reports quarterly revenue of $19.0M, net income of $-6.1M, free cash flow of $-1.8M. Top institutional holders of COSM by reported 13-F value include UBS Group AG, VANGUARD FIDUCIARY, JANE STREET GROUP, based on the most recent SEC filings. COSM trades on the Nasdaq exchange and files with the SEC under CIK 1474167. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate COSM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cosmos Health Inc. directly from SEC EDGAR.